Cart
sales@molnova.com
Home - Products - Others - Other Targets - Deferasirox

Deferasirox

CAS No. 201530-41-8

Deferasirox( ICL670A )

Catalog No. M13141 CAS No. 201530-41-8

An oral iron chelator that used to reduce chronic iron overload; also induces apoptosis in myeloid leukemia cells by targeting caspase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 46 In Stock
5MG 41 In Stock
10MG 58 In Stock
25MG 75 In Stock
50MG 111 In Stock
100MG 161 In Stock
200MG Get Quote In Stock
500MG 399 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Deferasirox
  • Note
    Research use only, not for human use.
  • Brief Description
    An oral iron chelator that used to reduce chronic iron overload; also induces apoptosis in myeloid leukemia cells by targeting caspase.
  • Description
    An oral iron chelator that used to reduce chronic iron overload; also induces apoptosis in myeloid leukemia cells by targeting caspase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ICL670A
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    iron
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    201530-41-8
  • Formula Weight
    373.3615
  • Molecular Formula
    C21H15N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(O)C1=CC=C(N2N=C(C3=CC=CC=C3O)N=C2C4=CC=CC=C4O)C=C1
  • Chemical Name
    Benzoic acid, 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sobbe A, et al. J Gastroenterol Hepatol. 2015 Mar;30(3):638-45. 2. Kim JL, et al. Acta Haematol. 2011;126(4):241-5. 3. Lee DH, et al. Exp Hematol. 2013 Jun;41(6):539-46.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Ethyl docosa-4,7,10,...

    Ethyl cis-4,7,10,13,16,19-Docosahexaenoate, the ethyl ester of Docosahexaenoate (DHA), is selectively enriched in the ethyl ester fraction through alcoholysis using fatty acid ethyl esters from tuna oil and lauryl alcohol.

  • R 715

    R715 is a selective bradykinin B1 receptor antagonist. R715 significantly attenuates the hyperalgesic effect developed in Streptozotocin -diabetic mice.

  • DL-Homocystine

    Homocystine is the double-bonded form of homocysteine but it occurs only transiently before being converted to the harmless cystathionine via a vitamin B6-dependent enzyme. Homocystine and homocysteine-cysteine mixed disulfide account for >98% of total homocysteine in plasma from healthy individuals.

Sign In Join Free